Plasmodium falciparum Malaria: Rosettes are Disrupted by Quinine, Artemisinin, Mefloquine, Primaquine, Pyrimethamine, Chloroquine and Proguanil

Memorias do Instituto Oswaldo Cruz

Volumn 94, Issue 5, 1999, Pages 667-674

  Goldring, J P Dean ^a   Padayachee, Thanugarani ^b   Ismail, Imraan ^b  

^a UNIVERSITY OF KWAZULU NATAL   (South Africa)

^b UNIVERSITY OF THE WITWATERSRAND   (South Africa)

Author keywords

Antimalarial drugs; Malaria; Plasmodium falciparum; Rosette disruption

Indexed keywords

CINCHONA PUBESCENS; PLASMODIUM FALCIPARUM;

ANTIMALARIAL AGENT; CHLOROQUINE; MEFLOQUINE; PRIMAQUINE; PROGUANIL; PYRIMETHAMINE; QUININE; QUINOLINE DERIVATIVE; SESQUITERPENE;

ANIMAL; ARTICLE; DOSE RESPONSE; DRUG EFFECT; ERYTHROCYTE; MALARIA FALCIPARUM; PARASITOLOGY; PLASMODIUM FALCIPARUM; ROSETTE FORMATION;

ANIMALS; ANTIMALARIALS; CHLOROGUANIDE; CHLOROQUINE; DOSE-RESPONSE RELATIONSHIP, DRUG; ERYTHROCYTES; MALARIA, FALCIPARUM; MEFLOQUINE; PLASMODIUM FALCIPARUM; PRIMAQUINE; PYRIMETHAMINE; QUININE; QUINOLINES; ROSETTE FORMATION; SESQUITERPENES;

EID: 0033192955     PISSN: 00740276     EISSN: None     Source Type: Journal    
DOI: 10.1590/s0074-02761999000500021     Document Type: Article

References (36)

1. Baker L, Van Schoor JD, Bartlet GA, Lombard JH 1993. Malaria prophylaxis - the South African viewpoint. SA Med J 83: 126-129.
2. Bansil L 1992. Antigenic and Genomic Diversity of Plasmodium falciparum Strains, PhD Thesis, University of Liverpool, United Kingdom, 120 pp.
3. Bunnag D, Kando T, Karbwang J, Thimasarn K, Pungpak S, Harinasuta T 1996. Artemether or artesunate followed by mcfloquine as a possible treatment for multidrug resistant falciparum malaria. Trans R Soc Trop Med Hyg 90: 415-417.
4. Carlson J, Wahlgren M 1992. Plasmodium falciparum erythrocyte rosetting is mediated by promiscuous lectin-like interactions. J Exp Med 176: 1311-1317.
5. Carlson J, Helmby H, Hill AVS, Brewster D, Greenwood BM, Wahlgren M 1990a. Human cerebral malaria: association with erythrocyte rosetting and lack of anti-rosetting antibodies. Lancet 336: 1457-1460.
6. Carlson J, Holmquist G, Taylor DW, Perlmann P, Wahlgren M 1990b. Antibodies to a histidine-rich protein (PfHRP1) disrupt spontaneously formed Plasmodium falciparum erythrocyte rosettes. Proc Natl Acad Sci USA 87: 2511-2515.
7. Chen Q, Barragan A, Fernandez V, Sundstrom A, Schlichtherle M, Sahlen A, Carlson J, Datta S, Wahlgren M 1998. Identification of Plasmodium falciparum erythrocyte membrane protein-1 (Pfemp1) as the rosetting ligand of malaria parasite Plasmodium falciparum. J Exp Med 187: 15-23.
8. David PH, Leech JH, Gamage P, Mendis KN, Handunnetti SM 1988. Rosetting: a new cytoadherence property of malaria-infected erythrocytes. Am J Trop Med Hyg 38: 289-297.
9. Desjardins RE, Doberstein EB, Wernsdorffer WH 1988. The treatment and prophylaxis of malaria, p. 827-823. In WH Wernsdorffer & I Mcgregor (eds). Malaria: Principles and Practice of Malariology, Churchill Livingstone, London.
10. Due DD, De Vries PJ, Khanh NX, Binh LNG, Kager PG, Boxtel CJ 1994. The pharmacokinetics of a single dose of artemisinin in healthy Vietnamese subjects. Am J Trop Med Hyg 51: 785-790.
11. Freese JA, Markus MB, Golenser J 1991. In vitro sensitivity of Southern African reference strains of Plasmodium falciparum to chloroquine and pyrimethamine. Bull WHO 69: 707-712.
12. Freese JA, Ridl FC, Sharp BL, Markus MB 1988. In vitro cultivation of Southern African strains of Plasmodium falciparum and gametocytogenesis. S A Med J 73: 720-722.
13. Goldring JPD, Molyneux ME, Taylor TE, Wirima JJ, Hommel M 1992. Plasmodium falciparum: diversity of strains from Malawi in their cytoadherence to melanoma cells and monocytes in vitro. Brit J Haematol 81: 413-418.
14. Helmby H. Cavilier L, Pettersson V, Wahlgren M 1993. Resetting Plasmodium falciparum-infected erythrocytes express unique strain-specific antigens on their surface. Infect Immun 61: 284-288.
15. Hommel M, Semoff S 1988. Expression and function of erythrocyte-associated surface antigens in malaria. Biol Cell 64: 183-203.
16. Jaing JB, Li GQ, Guo XB, Kong YC, Arnold K 1982. Antimalarial activity of mefloquine and quinhaosu. Lancet 293: 285-288.
17. Karbwang J, Na-Bangchang K, Thanavibul A. Ditta-in M, Harinasuta T 1995. A comparative clinical trial of two different regimens of artemether plus melloquine in multidrug resistant falciparum malaria. Trans R Soc Trop Med Hyg 89: 296-298.
18. Kaul DK, Roth EF, Nagel RL, Howard RJ, Handunnetti SM 1991. Rosetting of Plasmodium falciparum-infected red blood cells with uninfected red blood cells enhances microvascular obstruction under flow conditions. Blood 78: 812-819.
19. Lambross C, Vanderberg JP 1979. Synchronization of Plasmodium falciparum erythrocytic stages in culture. J Parasitol 65: 418-420.
20. Murphy S, English M, Waruiru C, Mwangi I, Amukoye E. Crawley J, Newton C, Winstanley P, Peshu N, Marsh K 1996. An open randomized trial of artemether versus quinine in the treatment of cerebral malaria in African children. Trans R Soc Trop Med Hyg 90: 298-301.
21. Peters W 1987. Drug evaluation III: clinical evaluation and follow-up, p. 260-263. In W Peters, Chemotherapy and Drug Resistance in Malaria, Vol. 1, 2nd ed., Academic Press, London.
22. Ringwald P, Peyron F, Lepers JP, Rabarison P, Rakotamalala C, Razanamparany M, Rabodonirina M. Roux J, LeBras J 1993. Parasite virulence factors during falciparum malaria: resetting, cytoadherence and modulation of cytoadherence by cytokines. Infect Immun 61: 5198-5204.
23. Rogerson SJ, Beck H-P. Al-Yaman F, Currie B, Alpers MP, Brown GV 1996. Disruption of crythrocyte rosettes and agglutination of erythrocytes infected with Plasmodium falciparum by the sera of Papua New Guineans. Trans R Soc Trop Med Hyg 90: 80-84.
24. Rogerson SJ, Reeder JC, Al-Yaman F, Brown GV 1994. Sulphated glycoconjugates as disrupters of Plasmodium falciparum erythrocytc rosettes. Am J Trop Med Hyg 51: 198-203.
25. Rowe JA, Berendt A, Marsh K, Newbold C 1994. Plasmodium falciparum: a family of sulphated glycoconjugates disrupts crythrocyte rosettes. Exp Parasitol 79: 506-516.
26. Rowe JA, Obeira J, Newbold C, Marsh K 1995. Plasmodium falciparum resetting is associated with malaria severity in Kenya. Infect Immun 63: 2323-2326.
27. Rowe JA, Moulds JM, Newbold C, Miller LH 1997. Plasmodium falciparum rosetting mediated by a parasite-variant erythrocyte membrane protein and complement receptor protein. Nature 388: 292-295.
28. Slutsker LM, Khoromana CO, Paune D, Allen CR, Wirima JJ, Heymann DL, Patchen L, Steketee RW 1990. Mefloquine therapy for Plasmodium falciparum malaria in children under 5 years of age in Malawi: in vivo/in vitro efficacy and correlation of drug concentration with parasitological outcome. Bull WHO 68: 53-59.
29. Sowunmi A, Oduola AMJ 1995. Open comparison of mefloquine, mefloquine/sulfadoxine/pyrimethamine and chloroquine in acute uncomplicated falciparum malaria in children. Trans R Soc Trop Med Hyg 89: 303-305.
30. Taylor RB, Behrens R, Moody RR, Wangboonskul J 1990. Assay method for the simultaneous determination of proguanil, chlorquine and their major metabolites n biological fluids. J Chromatog 527: 490-497.
31. Taylor TE, Molyneux ME, Wirima JJ, Borgstein A, Goldring JPD, Hommel MM 1992. Intravenous immunoglobulin in the treatment of paediatric cerebral malaria. Clin Exp Immunol 90: 357-362.
32. Taylor TE, Wills BA, Kazembie P, Chisale M, Wirima JJ, Ratsma EY, Molyneux ME 1993. Rapid coma resolution with artemether in children with cerebral malaria. Lancet 341: 661-662.
33. Trager W, Jensen JB 1976. Human malaria parasites in continuous culture. Science 193: 673-675.
34. Treutiger CJ, Hedlund I, Helmby H, Carlson J, Jepson A, Twumasi P, Kwiatkowski D, Greenwood BM, Wahlgren M 1992. Rosette formation in Plasmodium falciparum strains and anti-rosette activity of sera from Gambians with cerebral or uncomplicated malaria. Am J Trop Med Hyg 46: 503-510.
35. Udomsangpetch R, Pipitaporn B, Krishna S, Angus B, Pukrittayakamee S, Bates I, Suputtamongkol Y, Kyle DE, White NJ 1996. Antimalarial drugs reduce cytoadherence and resetting of Plasmodium falciparum. J Infect Dis 173: 691-698.
36. Webster LT 1990. Drugs used in the chemotherapy of protozoal infections, p. 978-998. In F Goodman & H Gilman (eds), The Pharmacological Basis of Therapeutics, 8th ed, McGraw-Hill Inc, New York.